SEC Form 4 · accession 0001209191-15-074834
AMICUS THERAPEUTICS, INC. · FOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John F Crowley
Officer — Chairman & CEO · Director
Period of report
Oct 7, 2015
Accepted (ET)
Oct 8, 2015 · 3:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 7, 2015 | M | 13,193 | $6.45 | A | 96,692 | D | |
| Common Stock | holding | — | — | — | 64,895 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy) | $6.45 | Oct 7, 2015 | M | 13,193 | D | Feb 15, 2013 | Feb 15, 2022 | Common Stock | 13,193 | 136,807 | D |
Remarks
The options were exercised for cash and represent all of the vested incentive stock options for this option grant. After this transaction, Mr. Crowley holds approximately 2.1 million options for shares of Amicus Therapeutics, Inc. common stock.